Division of Clinical Pharmacology, Department of Medical and Surgical Therapeutics, Medical School, University of Extremadura, Avda. de Elvas s/n, 06005, Badajoz, Spain.
Eur Child Adolesc Psychiatry. 2014 Aug;23(8):669-79. doi: 10.1007/s00787-013-0495-6. Epub 2013 Nov 29.
The brain-derived neurotrophic factor (BDNF) gene may influence eating behavior, body weight and cognitive impairments. We aimed to investigate whether BDNF genetic variability may affect anthropometric and psychological parameters in patients with anorexia or bulimia nervosa (AN, BN) and/or modulate the risk for the disorder. A total of 169 unrelated female patients and 312 healthy controls were genotyped for two common BDNF single-nucleotide polymorphisms (SNPs), Val66Met and C-270T, and several selected tag-SNPs. Associated personality characteristics and psychopathological symptoms were assessed by the EDI-2 and SCL-90R inventories, respectively. No single SNP or haplotype played a relevant role in the risk for AN or BN. The rs16917237 TT genotype was significantly associated with increased weight (74.63 ± 16.58 vs. 57.93 ± 13.02) and body mass index (28.94 ± 6.22 vs. 22.23 ± 4.77) in the BN group after correcting for multiple testing. Haplotype analyses using a sliding window approach with three adjacent SNPs produced four loci of interest. Locus 3 (rs10835210/rs16917237/C-270T) showed a broad impact on the measured psychopathological symptoms. Haplotypes CGC and CGT in this locus correlated with scores in all three scales of the SCL-90R inventory, both in AN and BN patients. In contrast, the results of the EDI-2 inventory were largely unaffected. These preliminary results suggest that variability in the BDNF gene locus may contribute to anthropometric characteristics and also psychopathological symptoms that are common but not exclusive of ED patients.
脑源性神经营养因子(BDNF)基因可能影响进食行为、体重和认知障碍。我们旨在研究 BDNF 遗传变异是否会影响厌食症或贪食症(AN、BN)患者的人体测量和心理参数,并调节发生该疾病的风险。共对 169 名无血缘关系的女性患者和 312 名健康对照者进行了两个常见的 BDNF 单核苷酸多态性(SNP),即 Val66Met 和 C-270T,以及几个选定的标签 SNP 的基因分型。通过 EDI-2 和 SCL-90R 量表分别评估相关的人格特征和精神病理学症状。没有单个 SNP 或单倍型在 AN 或 BN 的风险中起重要作用。在多重检验校正后,rs16917237 TT 基因型与 BN 组体重增加(74.63±16.58 与 57.93±13.02)和体重指数(28.94±6.22 与 22.23±4.77)显著相关。使用三个相邻 SNP 的滑动窗口方法进行的单体型分析产生了四个感兴趣的位点。位点 3(rs10835210/rs16917237/C-270T)对所测量的精神病理学症状有广泛影响。该位点的 CGC 和 CGT 单体型与 AN 和 BN 患者 SCL-90R 量表的所有三个量表的评分相关。相比之下,EDI-2 量表的结果基本不受影响。这些初步结果表明,BDNF 基因座的变异性可能有助于人体测量特征,也有助于常见但不限于 ED 患者的精神病理学症状。